There was an increasing trend in the incidence rate of patients with another Gram-negative pathogen in any site within ± 3 days of the index A. baumannii culture between 2018 and 2021 (Supplementary Table 1 ).
← all excerpts
Clinical burden of Acinetobacter baumannii, including carbapenem-resistant A. baumannii, in hospitalized adult patients in the USA between 2018 and 2022.
1
—
—